[Autoimmune hepatitis].
Shibata
Minoru
M
Department of Gastroenterology, Kanto Medical Center.
D000974:Antibodies, Antinuclear; D017951:Antigen Presentation; D001323:Autoantibodies; D001324:Autoantigens / Q000276:immunology; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D004359:Drug Therapy, Combination; D015804:HLA-DR4 Antigen / Q000276:immunology; D019693:Hepatitis, Autoimmune / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D009130:Muscle, Smooth / Q000276:immunology; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D012015:Reference Standards
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D001324:Autoantigens; D015804:HLA-DR4 Antigen; D007166:Immunosuppressive Agents; D011239:Prednisolone; D001379:Azathioprine